7/1/2026 Categories: Industries Angelini Industries: total revenues reach €1.7 billion (+4.6%). Growth in pharmaceuticals and industrial technology
6/16/2020 Categories: Industries Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101 for the Treatment of Angelman Syndrome in Europe
3/23/2020 Angelini Foundation in support of Lazzaro Spallanzani Hospital in the fight against Coronavirus
3/2/2020 Alessandra Favilli appointed External and Institutionale Relations Director of Angelini Holding
Angelini Industries
